Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Robinson · SciRah

Researcher profile · Semantic Scholar

S. Robinson

Share profile

S. Robinson — researcher profile on SciRah

h-index: 12
Works: 34
Citations: 1,518

Most-cited papers

Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions.
K. Fischer, O. Al-Sawaf, J. Bahlo, A. Fink +28 more
2019New England Journal of Medicine754 citations
Semantic Scholar
Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial.
O. Al-Sawaf, Can Zhang, M. Tandon, A. Sinha +22 more
2020The Lancet Oncology274 citations
Semantic Scholar
Venetoclax and obinutuzumab in chronic lymphocytic leukemia.
K. Fischer, O. Al-Sawaf, A. Fink, M. Dixon +23 more
2017Blood121 citations Open access
Semantic Scholar
A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study
M. Crump, D. Hedley, S. Kamel-Reid, B. Leber +11 more
2010Leukemia and Lymphoma92 citations
Semantic Scholar
A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7
C. Shustik, A. Belch, S. Robinson, S. Rubin +15 more
2007British Journal of Haematology82 citations Open access
Semantic Scholar
Defining ferritin clinical decision limits to improve diagnosis and treatment of iron deficiency: A modified Delphi study
K. Naveed, N. Goldberg, E. Shore, Arti Dhoot +15 more
2023International Journal of Laboratory Hematology27 citations
Semantic Scholar
Dexamethasone (dex) maintenance versus observation (obs) in patients with previously untreated multiple myeloma: A National Cancer Institute Of Canada Clinical Trials Group Study: MY.7.
C. Shustik, Andrew R. Belch, S. Robinson, S. Rubin +6 more
2004Journal of Clinical Oncology25 citations
Semantic Scholar
Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance).
J. Byrd, A. Ruppert, N. Heerema, Alese E. Halvorson +13 more
2018Blood Advances22 citations Open access
Semantic Scholar
The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL.
S. Assouline, Shen Li, C. Gisselbrecht, P. Fogarty +13 more
2020Blood Advances19 citations Open access
Semantic Scholar
Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update.
C. Owen, V. Banerji, Natalie Johnson, A. Gerrie +3 more
2023Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis17 citations Open access
Semantic Scholar
Randomized Phase III Trial Comparing ABVD + Radiotherapy and the Stanford V Regimen In Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the US Intergroup Trial E2496
R. Advani, F. Hong, R. Fisher, N. Bartlett +14 more
201015 citations
Semantic Scholar
Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study
S. Stilgenbauer, F. Bosch, O. Ilhan, J. Kisro +14 more
2021British Journal of Haematology12 citations Open access
Semantic Scholar
A Canadian Perspective: Monoclonal Antibodies for Pre- and Post-Exposure Protection from COVID-19 in Vulnerable Patients with Hematological Malignancies
C. Owen, S. Robinson, A. Christofides, L. Sehn
2022Current Oncology11 citations Open access
Semantic Scholar
Safety and Efficacy of Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) and Coexisting Medical Conditions: Final Results of the Run-in Phase of the Randomized CLL14 Trial (BO25323)
K. Fischer, O. Al-Sawaf, A. Fink, M. Dixon +22 more
201611 citations
Semantic Scholar
Bruton tyrosine kinase inhibitors for the frontline treatment of chronic lymphocytic leukemia.
V. Banerji, A. Aw, S. Robinson, S. Doucette +2 more
2020Current Oncology9 citations Open access
Semantic Scholar
Canadian evidence-based guideline for treatment of relapsed/refractory chronic lymphocytic leukemia.
C. Owen, Sarah Eisinga, V. Banerji, Natalie Johnson +4 more
2023Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis7 citations Open access
Semantic Scholar
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre‐autologous stem cell transplant in relapsed/refractory diffuse large B‐cell lymphoma—outcome of rituximab‐dose‐intensive cyclophosphamide, etoposide, cisplatin (R‐DICEP) versus R‐GDP
Douglas Stewart, J. Kuruvilla, David Lee, J. Dudebout +15 more
2024British Journal of Haematology6 citations Open access
Semantic Scholar
IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemia
S. Assouline, L. Amrein, R. Aloyz, V. Banerji +13 more
2020Leukemia and Lymphoma5 citations
Semantic Scholar
Defining Ferritin Clinical Decision Limits to Improve Diagnosis and Treatment of Iron Deficiency: A Modified Delphi Study
K. Naveed, N. Goldberg, E. Shore, Arti Dhoot +14 more
2022Blood3 citations Open access
Semantic Scholar
Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practice
V. Banerji, A. Aw, Nicole Laferriere, N. Abdel-Samad +10 more
2024Leukemia and Lymphoma2 citations Open access
Semantic Scholar
Event-Free Survival As a Surrogate for Overall Survival in Relapsed DLBCL after Autologous Transplant: A Subgroup Analysis of LY.12 and Coral
S. Assouline, Shen Li, C. Gisselbrecht, P. Fogarty +13 more
2019Blood2 citations Open access
Semantic Scholar
A Phase II Clinical Trial of the Pan PI3K Inhibitor, Buparlisib, for the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia: Canadian Cancer Trials Group IND.216
S. Assouline, L. Amrein, V. Banerji, S. Caplan +12 more
20172 citations
Semantic Scholar
A genetic risk-stratified, randomized phase 2 intergroup study of fludarabine/antibody combinations in symptomatic, untreated chronic lymphocytic leukemia (CLL): Results from Cancer and Leukemia Group B (CALGB) 10404 (Alliance).
A. Ruppert, J. Byrd, N. Heerema, Mitchell R. Smith +12 more
20172 citations
Semantic Scholar
A canadian perspective on the first-line treatment of chronic lymphocytic leukemia.
C. Owen, I. Bence-Bruckler, I. Chamakhi, C. Toze +3 more
2015Clinical Lymphoma, Myeloma & Leukemia2 citations
Semantic Scholar
The Empower Study - Design of a Randomized Clinical Trial to Assess the Efficacy and Safety of a Plasma-Derived Von Willebrand Factor / Factor VIII Concentrate for Heavy Menstrual Bleeding in Women with Von Willebrand Disease
M. Sholzberg, Grace H. Tang, P. James, F. Meffe +8 more
2022Blood1 citations Open access
Semantic Scholar
FIXED‐DURATION VENETOCLAX PLUS OBINUTUZUMAB IMPROVES PFS AND MINIMAL RESIDUAL DISEASE NEGATIVITY IN PATIENTS WITH PREVIOUSLY UNTREATED CLL AND COMORBIDITIES
K. Fischer, M. Porro Lurà, O. Al-Sawaf, J. Bahlo +29 more
2019Hematological Oncology1 citations
Semantic Scholar
Evaluation of the determinants of FVIII/FIX levels, bleeding score, and health-related quality of life in the Canadian hemophilia carriers (CHiC) study.
L. Swystun, J. Grabell, Megan Hinds, Maria Avgeropoulos +13 more
2026Journal of Thrombosis and Haemostasis0 citations Open access
Semantic Scholar
Understanding Treatment Care and Delays in Acquired Hemophilia A: A Population‐Based Study From Nova Scotia, Canada
R. Blackman, Lu-Ke Y. C. Chen, M. Keating, J. Quinn +1 more
2026eJHaem0 citations Open access
Semantic Scholar
OC 66.3 VWF and ABO Modify FVIII Activity and Bleeding Phenotype in Hemophilia A Carriers
J. Grabell, L. Swystun, Megan Hinds, Maria Avgeropoulos +13 more
2026Research and Practice in Thrombosis and Haemostasis0 citations Open access
Semantic Scholar
Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia After BTK Inhibitor and/or BCL-2 Inhibitor Failure
S. Robinson
2024Canadian Hematology Today0 citations Open access
Semantic Scholar
Corrigendum to "Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update" [Leukemia Research 125 (2023) 107016].
C. Owen, V. Banerji, Natalie Johnson, A. Gerrie +3 more
2023Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis0 citations Open access
Semantic Scholar
Canadian Cancer Trials Group (CCTG) LY.17: A Randomized Phase II Study Evaluating Novel Salvage Therapy Pre-Autologous Stem Cell Transplant (ASCT) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) - Outcome of Rituximab-Dose-Intensive Cyclophosphamide, Etoposide, Cisplatin (R-DICEP) Ve
D. Stewart, L. Shepherd, J. Dudebout, J. Larouche +13 more
2022Blood0 citations Open access
Semantic Scholar
CCTG on the world stage at ASCO 2017
S. Bratman, J. Ledermann, A. Embleton, T. Perren +32 more
20200 citations
Semantic Scholar
S149 FIXED-DURATION VENETOCLAX PLUS OBINUTUZUMAB IMPROVES PROGRESSION-FREE SURVIVAL AND MINIMAL RESIDUAL DISEASE NEGATIVITY IN PATIENTS WITH PREVIOUSLY UNTREATED CLL AND COMORBIDITIES
K. Fischer, O. Al-Sawaf, J. Bahlo, A. Fink +28 more
2019HemaSphere0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Owen×9
Invite
C. Owen — researcher profile on SciRah
E. Tausch×7
Invite
E. Tausch — researcher profile on SciRah
S. Stilgenbauer×7
Invite
S. Stilgenbauer — researcher profile on SciRah
V. Banerji×7
Invite
V. Banerji — researcher profile on SciRah

×6

Invite

K. Fischer — researcher profile on SciRah

Invite

O. Al-Sawaf — researcher profile on SciRah

Invite

A. Fink — researcher profile on SciRah

Stephen Samuel Opat×6

Invite

Stephen Samuel Opat — researcher profile on SciRah

Invite

R. Weinkove — researcher profile on SciRah

B. Eichhorst×6

Invite

B. Eichhorst — researcher profile on SciRah

Invite

C. Wendtner — researcher profile on SciRah

Invite

M. Ritgen — researcher profile on SciRah